WASHINGTON, Dec 3 - RIA Novosti, Alexey Bogdanovsky. Pfizer and its partner BioNTech will submit data on testing a vaccine against their own production of coronavirus to the American medical regulator FDA, and then to a scientific journal where scientists can review it, a Pfizer spokesman told RIA Novosti.
"The FDA has reported that a public meeting of the Vaccines and Similar Bioproducts Advisory Board (VRBPAC) will take place in the first half of December, at which meeting Pfizer and BioNTech will present safety and efficacy data already submitted to the FDA and answer questions from committee members." said a company spokesman.
"Pfizer and BioNTech plan to submit the efficacy and safety data from the study for peer review in a scientific journal after the analysis of the data is complete," he added. When this will happen, the company representative did not specify.
The coronavirus vaccine from pharmaceutical companies Pfizer and BioNTech was approved for use in the UK on Wednesday, and this issue is expected to be considered in the United States and other countries soon. According to Pfizer, the vaccine has proven to be highly effective.
The latest data on the situation with COVID-19 in Russia and the world are presented on the stopcoronavirus.rf portal
